FDA Offers Guidance to Enhance Diversity in Clinical Trials
The FDA released a statement (9 November 2020) outlining its commitment to promoting greater diversity in medical product development and issuing a new guidance document outlining the agency’s thinking on encouraging greater inclusivity. “Enhancing the Diversity of Clinical Trial Populations–Eligibility Criteria, Enrollment Practices, and Trial Designs.” The guidance provides recommendations for sponsors on how to
Cromos Pharma and Avance Clinical launch scalable clinical trial solution for biotech
Dublin/Ireland – Adelaide/Australia – Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in Australia and Central/Eastern Europe, respectively, are successfully collaborating on a scalable clinical solution for biotechs. The collaboration allows biotechs to quickly start their pre-IND early phase studies in Australia, then expand to Central/Eastern Europe to access
Video: Cromos Pharma and Avance Clinical Collaboration
Cromos Pharma and Avance Clinical with operations in Europe and Australia, respectively, are successfully collaborating on a scalable clinical solution for biotechs. The collaboration allows biotechs to quickly start their pre-IND early phase studies in Australia, then expand to Central/Eastern Europe to access the large patient populations for their Phase 2 and 3 studies. Importantly, the
